![]() |
市場調查報告書
商品編碼
2050408
全球供氣設備市場:市場規模、佔有率和趨勢分析(2026-2032 年)Insufflation Device Market Size, Share & Trends Analysis | Global | 2026-2032 | Includes: Insufflator, Veress Needle Markets, and 1 more |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
2025年全球供氣設備市場規模略低於6億美元。預計到2032年,該市場將以3.4%的年複合成長率成長,超過7.5億美元。
這份綜合報告涵蓋了全球絕緣設備市場,包括絕緣主機、絕緣管和貝雷斯針,這些設備整體腹腔鏡手術。
該分析包括銷售量、平均售價 (ASP)、市場規模、成長趨勢、市場促進因素和限制因素、截至 2032 年的市場預測以及截至 2022 年的歷史數據。它還涵蓋了近期併購、公司簡介、產品系列和主要參與者。
腹腔鏡手術數量的持續成長以及對配備先進空氣供應系統的更換的需求,是推動市場成長的主要因素。隨著醫院越來越重視手術煙霧安全,整合式排放和過濾功能預計將進一步促進市場成長。
市場概覽
全球供氣設備市場涵蓋用於在腹腔鏡手術中建立和維持腹腔內氣腹的系統和配件。這些產品對於微創手術至關重要,因為它們為外科醫生提供了必要的操作空間,以便觀察解剖結構並安全地進行手術。
該市場包括充氣主機、充氣管和貝雷斯針。充氣裝置控制氣體流量和壓力,充氣管連接氣源和患者介面系統,貝雷斯針用於在閉合式穿刺技術中建立腹腔內壓力。
供氣設備廣泛應用於一般外科、婦科及泌尿系統。其需求與腹腔鏡手術的數量、醫院的設備更換週期以及腹腔鏡手術在全球醫療保健系統中作為標準微創手術的持續地位密切相關。
市場成長預計將保持穩定,並主要受設備更換需求的驅動。目前市場已進入成熟階段,不斷湧現的新系統提供更高的流量、自適應壓力控制、加熱功能和煙霧管理功能,為醫院提供了升級現有設備的理由,尤其是在臨床或營運效益顯著的情況下。
市場促進因素
腹腔鏡手術的數量仍然是全球供氣設備市場的主要驅動力。腹腔鏡手術是全球最常用的微創手術方法之一,與傳統開放性手術相比,它具有恢復更快、住院時間更短、術後併發症更少、整體手術風險更低等優勢。
腹腔鏡手術技術仍然是外科訓練和臨床實踐的核心,其大量的手術量也支持了對腹腔充氣系統的需求。儘管機器人輔助手術不斷發展,但傳統腹腔鏡手術在大多數醫療系統中仍然是臨床和經濟上的標準治療方案,因此對腹腔供氣設備的需求仍然十分旺盛。
技術進步也推動了市場成長。流量更大、具備自適應壓力控制和整合加熱功能的供氣系統正在推動產品更換。此外,人們對術中煙霧暴露的日益關注,也促使他們對具備煙霧排放和過濾功能的多功能供氣平台產生了濃厚的興趣。
市場限制
持續使用哈森技術(開放式方法)會限制貝雷斯針段的生長。對於有腹部手術史或穿刺相關併發症高風險的患者,外科醫師可能更傾向於使用套管針進行穿刺,而不是使用貝雷斯針進行充氣。
因此,即使腹腔鏡手術數量保持穩定,貝雷斯針的應用仍然有限。這代表了更廣泛的供氣設備市場中一個特定領域的阻礙因素,尤其是在通常更傾向於開放式手術的環境中。
市場成熟度是另一個重要的阻礙因素。供氣設備市場主要受替換需求而非新安裝需求驅動。除非新系統具有明顯的臨床或操作優勢,否則醫院通常會長期使用供氣設備。缺乏明顯的差異化,會導致更換週期延長,從而限制銷售成長並減緩整體市場擴張。
市場覆蓋範圍和數據範圍
本報告旨在幫助讀者評估腹腔鏡手術數量、更換週期、煙霧管理要求和入路方式偏好等因素如何影響全球空氣灌注設備市場。
目標市場及區隔
充氣主機用於在腹腔鏡手術中調節氣體的流量和壓力。
空氣輸送管用於支撐空氣輸送系統與患者介面系統之間的氣體供應。
在閉式手術中,使用 Beres 針在腹腔鏡手術前建立腹腔內氣腹。
透過市場規模、市場佔有率、市場預測、市場成長率、銷售量和平均售價等相關定量指標對每個細分市場進行分析。
競爭分析
2025年,卡爾史托斯繼續引領全球供氣設備市場。該公司是北美第二大競爭對手,也是西歐最大的競爭對手。其ENDOFLATOR®和THERMOFFLATOR®產品是市場上最常用的供氣設備之一,鞏固了公司強大的全球市場地位。
史賽克是全球第二大競爭對手。該公司在北美市場佔據領先地位,並在拉丁美洲和亞洲保持強大的市場佔有率。史賽克豐富的產品系列鞏固了其在供氣設備領域的地位,尤其是在尋求整合手術技術解決方案的醫院中。
康美公司是全球腹腔供氣設備市場的第三大競爭對手。其AirSeal裝置具備先進的功能,包括煙霧排放、加熱以及氣體洩漏和系統故障的操作員警報。這些功能使康美公司在尋求多功能充氣平台(既能穩定腹腔內壓力又能控制手術煙霧)的醫療機構中佔據主導地位。
科技和醫療治療的發展趨勢
先進的腹腔充氣系統越來越注重在手術過程中維持穩定的腹腔內壓力。更精準的壓力控制有助於提高手術的穩定性,並減少因氣體洩漏和壓力波動造成的手術中斷。
此外,較高的氣流速率在現代供氣系統中也至關重要。這些特性有助於在頻繁更換器械或氣體外洩風險較高的手術中維持手術視野的穩定性。
整合加熱功能仍然發揮著至關重要的作用,因為它們可以改善腹腔鏡手術中的氣體調節。這些系統旨在透過改善手術過程中氣體的輸送方式來提高手術的舒適度和效率。
煙霧排放和過濾功能的重要性日益凸顯。手術過程中煙霧暴露問題正引起醫院、臨床醫生和安全團隊的廣泛關注,這也促使人們對能夠輔助微創手術煙霧管理的供氣設備和管道產生了濃厚的興趣。
作為更廣泛的煙霧管理流程的一部分,供氣管道也在不斷發展。具備過濾和吸氣功能的管道除了提供簡單的氣體供應外,還能帶來更多價值,尤其是在安全標準不斷更新的設施中。
儘管貝雷斯針仍佔有一席之地,但其成長受到外科醫生偏好和穿刺技術的限制。對於某些患者,特別是那些有腹部手術史的患者,臨床醫生可能更傾向於開放式手術或套管針輔助穿刺。
地區
本報告涵蓋全球調查區域,包括北美、歐洲、亞太地區、拉丁美洲以及中東和非洲。
全球供氣設備市場規模有多大?預計到 2032 年將如何成長?
在腹腔鏡手術中,充氣主機、充氣管和貝雷斯針取得了怎樣的成績?
隨著時間的推移,銷售量、平均售價和市場規模發生了哪些變化?
腹腔鏡手術的數量如何滿足對供氣設備的基本需求?
哪些先進功能(例如高流量、自適應壓力控制、加熱功能和煙霧管理)正在推動更換需求?
人們對手術煙霧暴露的認知不斷提高,這對產品開發和採購決策有何影響?
持續使用哈森方法如何限制貝雷斯針的生長?
哪些公司在供氣設備市場處於領先地位?卡爾史托斯、史賽克和康美德又處於什麼位置?
iData Research 的《全球供氣設備市場報告》透過詳盡的市場規模、平均售價 (ASP) 趨勢、預測和競爭格局分析,解答了這些問題。該報告可用於評估需求、與主要競爭對手進行比較、分析更換壓力,並制定全球供氣設備市場的成長計畫。
The global insufflation device market was valued at slightly below $600 million in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 3.4%, reaching over $750 million by 2032.
This comprehensive report covers the global market for insufflation devices, including insufflator consoles, insufflation tubing and Veress needles used across laparoscopic procedures.
The analysis includes unit sales, average selling prices (ASPs), market size, growth trends, market drivers and limiters, market forecasts through 2032, and historical data back to 2022. It also includes recent mergers and acquisitions, company profiles, product portfolios and leading competitors.
Growth in this market is supported by continued laparoscopic procedure volumes and replacement demand for insufflation systems with advanced features. Integrated smoke evacuation and filtration capabilities are expected to support incremental growth as hospitals place greater focus on surgical smoke safety.
Market Overview
The global insufflation device market includes the systems and accessories used to create and maintain pneumoperitoneum during laparoscopic surgery. These products are essential to minimally invasive procedures because they provide the working space surgeons need to visualize anatomy and operate safely.
The market includes insufflator consoles, insufflation tubing and Veress needles. Insufflators control gas flow and pressure, tubing connects the gas source to the patient interface, and Veress needles are used in closed-entry techniques to establish pneumoperitoneum.
Insufflation devices are used across general surgery, gynecology and urology. Demand is closely tied to laparoscopic procedure volumes, hospital replacement cycles and the continued role of laparoscopy as a standard minimally invasive surgical approach in global healthcare systems.
Market growth is expected to remain steady and replacement driven. While the market is mature, new systems with higher flow rates, adaptive pressure control, heating and smoke management features provide reasons for hospitals to upgrade existing equipment when clinical or operational benefits are clear.
Market Drivers
Laparoscopic procedure volume remains a core driver of the global insufflation device market. Laparoscopy is one of the most commonly performed minimally invasive techniques worldwide and offers faster recovery, shorter hospital stays, reduced post-operative complications and lower overall surgical risk compared to open surgery.
Because laparoscopic techniques remain central to surgical training and clinical practice, demand for insufflation systems is supported by high procedural volumes. Even as robotic-assisted surgery expands, traditional laparoscopy remains the clinical and economic standard of care across most healthcare systems, sustaining baseline demand for insufflation devices.
Technological development is also supporting market growth. Replacement demand is being driven by insufflation systems with higher flow rates, adaptive pressure control and integrated heating capabilities. Growing awareness of surgical smoke exposure has also increased interest in multifunctional insufflation platforms that include smoke evacuation or filtration features.
Market Limiters
The continued use of the Hasson, or open, technique limits growth in the Veress needle segment. In patients with prior abdominal surgery or higher risk of access-related complications, surgeons may prefer trocar-based entry instead of Veress needle insufflation.
As a result, Veress needle adoption remains constrained even when laparoscopic procedure volumes are stable. This creates a segment-specific limiter within the broader insufflation device market, especially in settings where open-entry techniques are commonly preferred.
Market maturity is another important limiter. The insufflator market is largely driven by replacement sales rather than new adoption. Hospitals often retain insufflators for extended periods unless new systems offer clear clinical or operational advantages. Without strong differentiation, replacement cycles may lengthen, limiting unit growth and moderating overall market expansion.
Market Coverage and Data Scope
The report is designed to help readers evaluate how laparoscopic procedure volumes, replacement cycles, smoke management requirements and access technique preferences are shaping the global insufflation device market.
Markets Covered and Segmentation
Insufflator consoles are used to regulate gas flow and pressure during laparoscopic procedures.
Insufflation tubing supports gas delivery between the insufflation system and the patient interface.
Veress needles are used in closed-entry techniques to establish pneumoperitoneum before laparoscopic access.
Each segment is analyzed through relevant quantitative measures, including market size, market shares, market forecasts, market growth rates, units sold and average selling prices.
Competitive Analysis
Karl Storz continued to lead the global insufflation device market in 2025. The company was the second-leading competitor in North America and the leading competitor in Western Europe. Its ENDOFLATOR(R) and THERMOFLATOR(R) products are among the most commonly used insufflators on the market, supporting the company's strong global position.
Stryker was the second-leading competitor globally. The company led the North American market and maintained a strong presence in Latin America and Asia. Stryker's broader minimally invasive surgery and operating room portfolio supports its position in insufflation, especially among hospitals seeking integrated surgical technology solutions.
CONMED was the third-leading competitor in the global insufflation device market. The company's AirSeal units offer advanced features, including smoke evacuation, heating and warning functions that alert operators to gas leaks and system failures. These capabilities position CONMED well in facilities seeking multifunctional insufflation platforms that support both pneumoperitoneum stability and surgical smoke management.
Technology and Practice Trends
Advanced insufflation systems are increasingly focused on maintaining stable pneumoperitoneum during surgery. Improved pressure control can help support procedural consistency and reduce interruptions caused by gas loss or pressure fluctuations.
Higher flow rates are also important in modern insufflation systems. These features can help maintain the surgical working space during procedures that involve frequent instrument exchanges or higher leakage risk.
Integrated heating capabilities remain relevant because they can improve gas conditioning during laparoscopic procedures. These systems are designed to support procedural comfort and efficiency by improving the way gas is delivered during surgery.
Smoke evacuation and filtration features are becoming more important. Surgical smoke exposure is receiving more attention from hospitals, clinicians and safety teams, which is supporting interest in insufflators and tubing that help manage smoke during minimally invasive procedures.
Insufflation tubing is also evolving as part of broader smoke management workflows. Tubing with filtration or evacuation capabilities can add value beyond basic gas delivery, especially in facilities updating safety standards.
Veress needles remain part of the market, but their growth is limited by surgeon preference and entry technique. In certain patients, especially those with prior abdominal surgery, clinicians may prefer open or trocar-based entry methods.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
How large is the global insufflation device market, and how is it expected to grow through 2032?
How are insufflator consoles, insufflation tubing and Veress needles performing across global laparoscopic procedures?
How are unit sales, average selling prices and market values changing over time?
How do laparoscopic procedure volumes support baseline demand for insufflation devices?
Which advanced features are driving replacement demand, including higher flow rates, adaptive pressure control, heating and smoke management?
How is growing awareness of surgical smoke exposure affecting product development and purchasing decisions?
How does continued use of the Hasson technique limit Veress needle growth?
Which companies lead the insufflation device market, and how are Karl Storz, Stryker and CONMED positioned?
The Global Insufflation Device Market Report from iData Research answers these questions with detailed market sizing, ASP trends, forecasts and competitive share insights. Use it to evaluate demand, benchmark leading competitors, assess replacement cycle pressure and plan for growth across the global insufflation device market.